Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
151 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Mohamed Ismail Omar Ali 2021
152 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2021
153 Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
154 Assessment of Humoral Immune Recovery in Children with Hematological malignancies after Completion of Chemotherapy Department of Pediatric Oncology Rania Taha Mohammed Ahmed 2021
155 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Doaa Mohamed Fouad Mahmoud 2021
156 Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma Department of Pathology Saly Salah Abdelhakeem 2021
157 Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute Department of Radiotherapy and Nuclear medicine Dr. Dalia Osama Mohamed Ahmed 2021
158 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Murad Aly Jabir Ahmed 2021
159 Assessment of Humoral Immune Recovery in Children with Hematological malignancies after Completion of Chemotherapy Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2021
160 Relationship of transitional regulatory B and regulatory T cells and immunosuppressive drug doses in stable renal transplant recipients Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2021